Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VTX2735 in Recurrent Pericarditis
NCT06836232Phase 2Recruiting
- Sponsor
- Zomagen Biosciences
- Start
- Jan 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of VTX2735 in recurrent pericarditis, sponsored by Zomagen Biosciences. Started Jan 2025; status: recruiting.
02
Drugs
VTX2735
03
Conditions
recurrent pericarditis
Beyond the preview
Go deeper on NCT06836232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06836232.